Fate and Effect of Intravenously Infused Mesenchymal Stem Cells in a Mouse Model of Hepatic Ischemia Reperfusion Injury and Resection
Liver ischemia reperfusion injury (IRI) is inevitable during transplantation and resection and is characterized by hepatocellular injury. Therapeutic strategies to reduce IRI and accelerate regeneration could offer major benefits. Mesenchymal stem cells (MSC) are reported to have anti-inflammatory a...
Main Authors: | Saat, T. C., van den Engel, S., Bijman-Lachger, W., Korevaar, S. S., Hoogduijn, M. J., IJzermans, J. N. M., de Bruin, R. W. F. |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766354/ |
Similar Items
-
The Life and Fate of Mesenchymal Stem Cells
by: Eggenhofer, Elke, et al.
Published: (2014) -
Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation?
by: Saat, T. C., et al.
Published: (2016) -
The Effect of Intravenous Anesthetics on Ischemia-Reperfusion Injury
by: Eroglu, Ahmet
Published: (2014) -
Preoperative Fasting Protects against Renal Ischemia-Reperfusion Injury in Aged and Overweight Mice
by: Jongbloed, Franny, et al.
Published: (2014) -
Mesenchymal stromal cells in renal ischemia/reperfusion injury
by: de Vries, Dorottya K., et al.
Published: (2012)